Mechanism of Action and Pharmacologic Features of Drugs Targeting PD‐1/PDL‐1 and CTLA‐4
MA Rodriguez, R Bucktrout, A Orlando… - … Therapies vol 2 …, 2024 - Wiley Online Library
The discovery of immune checkpoint proteins such as PD‐1/PD‐L1 and CTLA‐4 triggered a
revolution in the field of cancer immunotherapy, with antibodies (Abs) blocking these …
revolution in the field of cancer immunotherapy, with antibodies (Abs) blocking these …
[HTML][HTML] Tumor microenvironment of follicular lymphoma
K Nath, H Tsang, MK Gandhi - Annals of Lymphoma, 2021 - aol.amegroups.org
Follicular lymphoma (FL) is the second most common type of non-Hodgkin lymphoma and
accounts for approximately 20% of all new non-Hodgkin lymphomas in western countries …
accounts for approximately 20% of all new non-Hodgkin lymphomas in western countries …
[图书][B] Prognostic insights from multiplexed spatial profiling of the tumour microenvironment
AM Tsakiroglou - 2021 - search.proquest.com
Fulfilling the promise of cancer immunotherapy would benefit from novel biomarkers to
characterise the tumour microenvironment and risk-stratify patients. Multiplex …
characterise the tumour microenvironment and risk-stratify patients. Multiplex …
[引用][C] A comprehensive study of intratumoural T-cells in follicular lymphoma
K Nath - 2022 - espace.library.uq.edu.au
Follicular lymphoma is the most common indolent non-Hodgkin Lymphoma. Despite most
patients having excellent survival, there are a subset of patients that have poor outcomes …
patients having excellent survival, there are a subset of patients that have poor outcomes …